6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

15 trials found

diseases per page:

Showing 1 to 10 of 15 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR2000037828	2020-09-01	2020-09-02	Clinical study of Wuqinxi combined with selegilan in improving frozen gait of Parkinson's disease	Clinical study of Wuqinxi combined with selegilan in improving frozen gait of Parkinson's disease	Parkinson's disease	Group 1:Routine anti PD treatment + stretching training;Group 2:Routine anti PD treatment + stretchi ...	Union Medical College Affiliated Hospital of Tongji Medical College, Huazhong University of science ...	NULL	Recruiting	40	80	Male	Group 1:30;Group 2:30;Group 3:30;Group 4:30;		China
2	ChiCTR2100045946	2020-03-01	2021-04-30	Improved Excessive Daytime Sleepiness with Selegiline in Parkinson’s Disease: An Open Trial	Improved Excessive Daytime Sleepiness with Selegiline in Parkinson‘s Disease: An Open Trial	Parkinson's Diseases	Selegiline Group:Selegiline;	The Second Affiliated Hospital of Soochow University	NULL	Completed	30	80	Both	Selegiline Group:140;	Phase 4	China
3	NCT04870372 (ClinicalTrials.gov)	March 1, 2020	15/1/2020	Selegiline for the Treatment of Excessive Daytime Sleepiness in Parkinson's Disease	A Multi-center, Open-Label Study to Evaluate the Efficacy and Safety of Selegilinefor the Treatment ...	Parkinson Disease	Drug: Selegiline	Second Affiliated Hospital of Soochow University	NULL	Completed	30 Years	80 Years	All	141	Phase 4	China
4	JPRN-jRCTs051180098	09/06/2016	06/03/2019	The DAT-SPECT study for the benefit of Selegilline or Zonisamide in Parkinson's Disease	A comparative randomized study for the evaluation of the overlaying effect of Selegilineor Zonisamid ...	Parkinson's disease;034034	L-Dopa/DCIonly : The drug is administered per oral at 300 mg/day. The treatment is started within 14 ...	Ito Hidefumi	NULL	Not Recruiting	>= 55age old	< 80age old	Both	120	Phase 2	Japan
5	JPRN-UMIN000022533	2016/06/01	01/06/2016	A comparative randomized study for the evaluation of the overlaying effect of Selegilineor Zonisamid ...	A comparative randomized study for the evaluation of the overlaying effect of Selegilineor Zonisamid ...	Parkinson's disease	L-Dopa/DCIonly The drug is administered per oral at 150 to 300 mg/day. The treatment is started withi ...	Osaka Redcross HospitalWakayama Prefectural Medical College	NULL	Recruiting	55years-old	80years-old	Male and Female	180	Phase 2	Japan
6	EUCTR2014-000335-17-GB (EUCTR)	28/10/2014	23/07/2014	Rotigotine and memory in Parkinson's.	The Effect of Rotigotine on Memory in Idiopathic Parkinson's Disease without Cognitive Impairment - ...	Idiopathic Parkinson's Disease;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]	Product Name: rotigotine INN or Proposed INN: Rotigotine Product Name: levodopa CR (controlled release) ...	Research and Development University Hospital of North Staffordshire	Keele University	Not Recruiting			Female: yes Male: yes	0		United Kingdom
7	NCT02225548 (ClinicalTrials.gov)	September 2014	22/8/2014	Sagene 2014 - Parkinson's Disease and Erectile Dysfunction	An Open-label Trial of Oral Selegiline5 or 10 mg and Tadalafil 2.5mg Co-administration to Male Patie ...	Parkinson's Disease;Erectile Dysfunction	Drug: Selegiline;Drug: Tadalafil	University of South Florida	NULL	Recruiting	40 Years	64 Years	Male	10	Phase 4	United States
8	JPRN-UMIN000008477	2012/07/19	19/07/2012	Clinical study of selegilinehydrochloride ( FP OD tablet 2.5) to flexion of spine in Parkinson's dis ...	Clinical study of selegilinehydrochloride ( FP OD tablet 2.5) to flexion of spine in Parkinson's dis ...	Parkinson disease	Selegilinehydrochloride 5mg 8weeks, 7.5mg 8weeks and stop it, followed after 8weeks, and evaluate ea ...	Department of Neurology, Juntendo Koshigaya Hospital	NULL	Complete: follow-up complete	20years-old	Not applicable	Male and Female	20	Not selected	Japan
9	JPRN-JapicCTI-122000	01/4/2012	02/11/2012	Long-term study of FPF1100NW monotherapy	Long-term study on FPF1100NW monotherapy with early Parkinson's disease patients	Early Parkinson's disease	Intervention name : FPF1100NW INN of the intervention : Selegiline Dosage And administration of the in ...	FP Pharmaceutical Corp.	NULL				BOTH	130	Phase 2	NULL
10	EUCTR2010-020769-25-FR (EUCTR)	10/08/2010	09/07/2010	Evaluation médico-économique de l’infusion continue intra-duodénale d’une forme gélifiée de levodopa ...	Evaluation médico-économique de l’infusion continue intra-duodénale d’une forme gélifiée de levodopa ...	Parkinson's disease MedDRA version: 12.1;Level: LLT;Classification code 10034006;Term: Parkinson's d ...	Trade Name: DUODOPA INN or Proposed INN: LEVODOPA /CARBIDOPA INN or Proposed INN: LEVODOPA /BENZERASIDE I ...	CHU de Poitiers	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			France

First Previous1 2Next Last